Being LiterateNCT06979960
The Effect of Face-to-Face and Online Training on Cancer Screening on Women's Knowledge, Attıtude and Shyness
A study testing cancer screening education in people with Being Literate and Not Having Any Cognitive, Visual or Orthopedic Disabilities, run by Inonu University at 1 site in Turkey (Türkiye).
Trial summary
Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Read more about this study
- Who is it for?
- Ages 50 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Being Literate, Not Having Any Cognitive, Visual or Orthopedic Disabilities, Being Between the Ages of 50-65
- What is being tested?
- cancer screening education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 68 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2024to 31 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being between the ages of 50-65
- Being literate
- Having a smart mobile phone
- No cognitive, visual or orthopedic disabilities
Who cannot join
- Not answering questions completely. Being diagnosed with a psychiatric disease.
Trial locations and contacts
1 site in 1 country.
About this study
Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Cancer screening aims to detect it in the early stages when the chance of treatment is high. Screening programs for breast cancer, cervical cancer and colorectal cancer are recommended by WHO. In order for these screening programs to achieve their goals, people within the scope of screening must participate in screening. However, there are many factors involved in participating in these screening programs. Even though health professionals direct people to screening programs, at this point people's knowledge, attitude and shyness levels affect their participation in screening programs. The research is planned to be experimentally pre-test-post-test, and the data will be collected before and after the training to be given face-to-face and online by the researcher. The results obtained as a result of the study will be taken into consideration by midwives in terms of the effect of the education given on cancer screenings on women's knowledge, attitude and shyness levels.
- Conditions
- Being Literate, Not Having Any Cognitive, Visual or Orthopedic Disabilities, Being Between the Ages of 50-65, Having a Smart Phone, The Effect of Education on Cancer Screening on the Knowledge Level of Women, The Effect of Education on Cancer Screening on Women&Amp;#39;s Attitudes
- Being tested
- cancer screening education
- Keywords
- cancer screenings, midwife, knowledge, attitude, shyness, woman, online education
- Medical subject headings
- Behavior, Shyness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cancer screening educationBehavioural
It will be carried out to examine the effect of the educational intervention given using the cancer screening training booklet on women's knowledge, attitude and shyness levels.
| Study group | Role | What they receive |
|---|---|---|
| training group | Experimental | First interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet.
Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held.
Third interview: A reminder training was held over the phone 1 week after the second training.
Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented. Receives: Behavioral: cancer screening education |
| control group | No intervention | The women in the control group who applied to the Ketem unit were introduced to the first interview and their written consent was obtained, and then the personal information form and scales were applied. After the personal information form and scales were applied again 4 weeks after the first interview, the post-test data were obtained. After the post-test data were obtained, the women in the control group, who were not subjected to any intervention, were given an educational booklet in line with the "Equality" principle. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge Scale for Cancer Screening
This scale, which consists of 25 items and 3 sub-dimensions, has no special names for its sub-dimensions. The scale; The items in the 1st sub-dimension are items 8, 17-23, 25, 28, totaling 10 items, The items in the 2nd sub-dimension are items 4, 5, 7, 10, 12,13, 15, 16, 27, totaling 9 items,The items in the 3rd sub-dimension are items 1-3, 9, 11, 24, totaling 6 items. This scale, which is answered in a range from 1 to 3 as ''1: True, 2: False, 3: I don't know'', is a three-point rating type. When calculating the scale score, the ''True'' answers are given 1 point, and the ''False'' and ''I don't know'' answers are given 0 points. The lowest possible score for this scale is 0, and the highest possible score is 25. Items 2, 11, and 24 of this scale, which has three negatively connoted items, should be reverse coded. The order of use of the items in the scale is not important and researchers can use them in a mixed order.
Measured: first day encountered
Attitude Scale Towards Cancer Screening
The Attitude Scale Towards Cancer Screenings was developed by Yıldırım Öztürk and his colleagues in 2020, and its Turkish validity and reliability study was conducted. This scale, consisting of 24 items and a single dimension, is a five-point Likert-type scale. The items of the scale, which are answered in the range of 1 to 5, are as follows: 1: I completely disagree, 2: I somewhat disagree, 3: I neither agree nor disagree, 4: I somewhat agree, 5: I completely agree. This scale is suitable for evaluating individuals whose age range is 30-70, whose education level is at least literate, and who do not have cognitive, visual or orthopedic disabilities that would prevent them from answering the questions on the scale. There is no specific cut-off point for this scale, where the lowest score is 24 and the highest is 120.Scores close to 24 on the scale indicate that individuals have a negative attitude towards cancer screening.
Measured: first day encountered
Shyness scale
This scale, which is a 5-point Likert-type scale ranging from 1 to 5, has 20 items that include expressions regarding feelings and behaviors that can be used to determine how shy individuals perceive themselves as. Individuals are asked to mark one of the following answers opposite the statements on the scale: "Not at all suitable for me," "Not suitable," "Undecided," or "Very suitable for me." As a result, the calculation is made by giving 1 (One) point to the item "Not at all suitable for me," 2 (Two) points to the item "Not suitable for me," 3 (Three) points to the item "Undecided," 4 (Four) points to the item "Suitable for me," and 5 (Five) points to the item "Very suitable for me." The lowest score that can be obtained from the scale is 20, while the highest score is 100. A high score on the scale indicates that the individual perceives himself as "shy."
Measured: first day encountered
Secondary outcomes (3)
Attitude Scale Towards Cancer Screening
The Attitude Scale Towards Cancer Screenings was developed by Yıldırım Öztürk and his colleagues in 2020, and its Turkish validity and reliability study was conducted. This scale, consisting of 24 items and a single dimension, is a five-point Likert-type scale. The items of the scale, which are answered in the range of 1 to 5, are as follows: 1: I completely disagree, 2: I somewhat disagree, 3: I neither agree nor disagree, 4: I somewhat agree, 5: I completely agree. This scale is suitable for evaluating individuals whose age range is 30-70, whose education level is at least literate, and who do not have cognitive, visual or orthopedic disabilities that would prevent them from answering the questions on the scale. There is no specific cut-off point for this scale, where the lowest score is 24 and the highest is 120. Scores close to 24 on the scale indicate that individuals have a negative attitude towards cancer screening.
Measured: up to 4th week after registration
Knowledge Scale for Cancer Screening
This scale, which consists of 25 items and 3 sub-dimensions, has no special names for its sub-dimensions. The scale; The items in the 1st sub-dimension are items 8, 17-23, 25, 28, totaling 10 items, The items in the 2nd sub-dimension are items 4, 5, 7, 10, 12,13, 15, 16, 27, totaling 9 items,The items in the 3rd sub-dimension are items 1-3, 9, 11, 24, totaling 6 items. This scale, which is answered in a range from 1 to 3 as ''1: True, 2: False, 3: I don't know'', is a three-point rating type. When calculating the scale score, the ''True'' answers are given 1 point, and the ''False'' and ''I don't know'' answers are given 0 points. The lowest possible score for this scale is 0, and the highest possible score is 25. Items 2, 11, and 24 of this scale, which has three negatively connoted items, should be reverse coded. The order of use of the items in the scale is not important and researchers can use them in a mixed order.
Measured: up to 4th week after registration
Shyness scale
This scale, which is a 5-point Likert-type scale ranging from 1 to 5, has 20 items that include expressions regarding feelings and behaviors that can be used to determine how shy individuals perceive themselves as. Individuals are asked to mark one of the following answers opposite the statements on the scale: "Not at all suitable for me," "Not suitable," "Undecided," or "Very suitable for me." As a result, the calculation is made by giving 1 (One) point to the item "Not at all suitable for me," 2 (Two) points to the item "Not suitable for me," 3 (Three) points to the item "Undecided," 4 (Four) points to the item "Suitable for me," and 5 (Five) points to the item "Very suitable for me." The lowest score that can be obtained from the scale is 20, while the highest score is 100. A high score on the scale indicates that the individual perceives himself as "shy."
Measured: up to 4th week after registration
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2025
- Study start1 Sep 2024
- Primary completion31 Dec 2024
- Study completion31 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Being LiterateStudies of the same condition, open and under way.
- More trials run by Inonu UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Experimental Group; First interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet. Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held.Third interview: A reminder training was held over the phone 1 weekafter the second training.Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented.Control Group;no action taken
- Masking
- None (open label)
- Enrolment
- 68 participants (actual)
Sponsor and investigators
- Lead sponsor
- Inonu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Melike Kutluol, Inonu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06979960
- Sponsor's protocol ID
- 2024/5731
- Status last verified
- Feb 2025
- First submitted
- 2 May 2025
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all IPD underlying results in a publication
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Face-to-Face and Online Training on Cancer Screening on Women's Knowledge, Attıtude and Shyness
- ClinicalTrials.gov ID
- NCT06979960
- Acronym / sponsor ID
- 2024/5731
- Conditions
- Being Literate, Not Having Any Cognitive, Visual or Orthopedic Disabilities, Being Between the Ages of 50-65, Having a Smart Phone, The Effect of Education on Cancer Screening on the Knowledge Level of Women, The Effect of Education on Cancer Screening on Women&Amp;#39;s Attitudes
- Keywords
- cancer screenings, midwife, knowledge, attitude, shyness, woman, online education
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 68 participants (actual)
- Lead sponsor
- Inonu UniversityUniversity, hospital or other
- Study start
- 1 Sep 2024 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- 31 May 2025 (actual)
- First posted
- 20 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Cancer screening aims to detect it in the early stages when the chance of treatment is high. Screening programs for breast cancer, cervical cancer and colorectal cancer are recommended by WHO. In order for these screening programs to achieve their goals, people within the scope of screening must participate in screening. However, there are many factors involved in participating in these screening programs. Even though health professionals direct people to screening programs, at this point people's knowledge, attitude and shyness levels affect their participation in screening programs. The research is planned to be experimentally pre-test-post-test, and the data will be collected before and after the training to be given face-to-face and online by the researcher. The results obtained as a result of the study will be taken into consideration by midwives in terms of the effect of the education given on cancer screenings on women's knowledge, attitude and shyness levels.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Experimental Group; First interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet. Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held.Third interview: A reminder training was held over the phone 1 weekafter the second training.Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented.Control Group;no action taken
| Arm | Type | Receives |
|---|---|---|
| training group | Experimental | Behavioral: cancer screening educationFirst interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet. Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held. Third interview: A reminder training was held over the phone 1 week after the second training. Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented. |
| control group | No intervention | –The women in the control group who applied to the Ketem unit were introduced to the first interview and their written consent was obtained, and then the personal information form and scales were applied. After the personal information form and scales were applied again 4 weeks after the first interview, the post-test data were obtained. After the post-test data were obtained, the women in the control group, who were not subjected to any intervention, were given an educational booklet in line with the "Equality" principle. |
Who may qualify
- Ages
- 50 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Being between the ages of 50-65
- Being literate
- Having a smart mobile phone
- No cognitive, visual or orthopedic disabilities
Key exclusion criteria (1 listed)
- Not answering questions completely. Being diagnosed with a psychiatric disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cancer screening educationIt will be carried out to examine the effect of the educational intervention given using the cancer screening training booklet on women's knowledge, attitude and shyness levels. | Behavioural | training group |
Primary outcome
Knowledge Scale for Cancer Screening
Time frame: first day encountered
This scale, which consists of 25 items and 3 sub-dimensions, has no special names for its sub-dimensions. The scale; The items in the 1st sub-dimension are items 8, 17-23, 25, 28, totaling 10 items, The items in the 2nd sub-dimension are items 4, 5, 7, 10, 12,13, 15, 16, 27, totaling 9 items,The items in the 3rd sub-dimension are items 1-3, 9, 11, 24, totaling 6 items. This scale, which is answered in a range from 1 to 3 as ''1: True, 2: False, 3: I don't know'', is a three-point rating type. When calculating the scale score, the ''True'' answers are given 1 point, and the ''False'' and ''I don't know'' answers are given 0 points. The lowest possible score for this scale is 0, and the highest possible score is 25. Items 2, 11, and 24 of this scale, which has three negatively connoted items, should be reverse coded. The order of use of the items in the scale is not important and researchers can use them in a mixed order.
Attitude Scale Towards Cancer Screening
Time frame: first day encountered
The Attitude Scale Towards Cancer Screenings was developed by Yıldırım Öztürk and his colleagues in 2020, and its Turkish validity and reliability study was conducted. This scale, consisting of 24 items and a single dimension, is a five-point Likert-type scale. The items of the scale, which are answered in the range of 1 to 5, are as follows: 1: I completely disagree, 2: I somewhat disagree, 3: I neither agree nor disagree, 4: I somewhat agree, 5: I completely agree. This scale is suitable for evaluating individuals whose age range is 30-70, whose education level is at least literate, and who do not have cognitive, visual or orthopedic disabilities that would prevent them from answering the questions on the scale. There is no specific cut-off point for this scale, where the lowest score is 24 and the highest is 120.Scores close to 24 on the scale indicate that individuals have a negative attitude towards cancer screening.
Shyness scale
Time frame: first day encountered
This scale, which is a 5-point Likert-type scale ranging from 1 to 5, has 20 items that include expressions regarding feelings and behaviors that can be used to determine how shy individuals perceive themselves as. Individuals are asked to mark one of the following answers opposite the statements on the scale: "Not at all suitable for me," "Not suitable," "Undecided," or "Very suitable for me." As a result, the calculation is made by giving 1 (One) point to the item "Not at all suitable for me," 2 (Two) points to the item "Not suitable for me," 3 (Three) points to the item "Undecided," 4 (Four) points to the item "Suitable for me," and 5 (Five) points to the item "Very suitable for me." The lowest score that can be obtained from the scale is 20, while the highest score is 100. A high score on the scale indicates that the individual perceives himself as "shy."
3 secondary outcomes
Attitude Scale Towards Cancer Screening
Time frame: up to 4th week after registration
Knowledge Scale for Cancer Screening
Time frame: up to 4th week after registration
Shyness scale
Time frame: up to 4th week after registration
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Individual participant dataSharing planned: Yes. all IPD underlying results in a publication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing cancer screening education in people with Being Literate and Not Having Any Cognitive, Visual or Orthopedic Disabilities, run by Inonu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge Scale for Cancer Screening (time frame: first day encountered). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026; AzTrials last refreshed its copy on 6 Nov 2026.